Author Archives: Julian Upton
By Julian Upton | Published: February 20, 2013
Cuts to US global health and research programs for diseases such as AIDS, tuberculosis and malaria risk derailing the innovations crucial to fighting these diseases, according a new report by the Global Health Technologies Coalition.
By Julian Upton | Published: January 2, 2013
In its new study on pharma market growth in Africa, IMS Health highlights three ‘rising star’ countries from the continent’s sub-Saharan region.
By Julian Upton | Published: November 14, 2012
Greece took its part on Wednesday in the latest widespread strikes against austerity measures that swept across Europe, throwing travel networks into disarray and sparking violent clashes between police and workers. But for once Greece wasn’t at the forefront of the misery as the country has been thrown a couple more lifelines — not least [...]
By Julian Upton | Published: July 25, 2012
Industry is finding it harder to secure market access and payer uptake for new products. Innovative contracting may offer a solution. But is it working? Andrea Sobrio reports. How can a pharmaceutical company convince payers that a new treatment is worth budgeting for? Many companies have shifted the weight of their resources to payers and key [...]
By Julian Upton | Published: July 24, 2012
It’s an unusual sight in the UK — a television commercial for a Big Pharma company. But among the cultural and commercial innovations being attributed to the London Olympic Games is GSK’s first UK consumer-facing corporate brand campaign, showcasing its anti-doping operations. The TV ad debuted on July 16; this week, the company’s campaign went [...]